Jupiter Neurosciences, Inc.JUNSNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank44
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P44
Within normal range
vs 3Y Ago
-0.5x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q3 2025-39.39%
Q2 202522.09%
Q1 202571.24%
Q4 2024-8575.94%
Q3 202460.36%
Q2 2024-64.91%
Q1 202459.56%
Q4 20231.25%
Q3 2023-181.57%
Q2 202341.28%
Q1 20230.00%
Q2 2022-149.85%
Q1 202282.16%
Q4 2021-107.70%
Q3 2021-595.24%
Q2 2021-300.90%
Q1 2021-75.10%
Q4 2020154.40%
Q3 20200.00%